Patent Assignment
Reel/Frame 048318/0006
Assignment of Assignor's Interest
Recorded: 2019-02-13
Pages: 4
Assignor
RATIOPHARM GMBH
Executed: 2019-02-13
Assignee
89BIO LTD.
6 HAMADA STREET, HERZLIYA, 4673340, ISRAEL
Covered Properties
(2)
Remodeling and Glycopegylation of Fibroblast Growth Factor (Fgf)
A Method of Treating of Fibroblast Growth Factor 21 (Fgf-21) Deficiency
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 21, 2019
From: RATIOPHARM GMBH; TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.
To: 89BIO LTD.
Reel/Frame 050112/0408 →
Corrective Assignment to Correct the Application Number 62/623342 Previously Recorded on Reel 050112 Frame 0408. Assignor(S) Hereby Confirms the License Assignment.
Oct 24, 2019
From: RATIOPHARM GMBH; TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.
To: 89BIO LTD.
Reel/Frame 050817/0001 →
Assignment of Assignor's Interest
Jul 8, 2020
From: NOVO NORDISK A/S
To: RATIOPHARM GMBH
Reel/Frame 053147/0057 →
Assignment of Assignor's Interest
Mar 14, 2023
From: DEFREES, SHAWN
To: NEOSE TECHNOLOGIES, INC
Reel/Frame 062981/0931 →
Assignment of Assignor's Interest
Mar 14, 2023
From: NEOSE TECHNOLOGIES, INC
To: NOVO NORDISK A/S
Reel/Frame 062981/0963 →
Assignment of Assignor's Interest
Oct 6, 2025
From: 89BIO LTD.
To: 89BIO, INC.
Reel/Frame 072478/0305 →